Navigation Links
Prostate Cancer: The Father's Day Gift You Never Thought About
Date:6/14/2010

MARLTON, N.J., June 14 /PRNewswire/ -- While Father's Day gifts range from the touching to the hilarious, the best gift you might give your father or spouse is help and support during the difficult time of a cancer diagnosis.

Often men have tremendous difficulties deciding about their treatment, which can add to needless distress and side effects, says Michael Diefenbach, Ph.D., associate professor of Urology at Mount Sinai School of Medicine in New York and the lead investigator of Healing Choices, a new prostate cancer study.

Compounding the problem is the added strain this places on the wife.

"Prostate cancer is a family disease, and the spouse is usually heavily involved in his care and has to cope with the physical and emotional changes of their partner," says Diefenbach.

Also, most men follow the recommendation of the first specialist they're seeing, even though other options might exist and that they usually have time to make an informed decision, Diefenbach explains.  

The Cancer Information Service Research Consortium (CISRC) is conducting a Healing Choices study that will try to determine if receiving a multimedia presentation of medical options helps patients make informed treatment decisions.

Patients who call toll-free, 866-258-7981, will receive one of two information packets, depending on which part of the study they become enrolled in. Some will receive a free, multimedia program and printed material. Others will receive only printed material.

Both groups will receive information that outlines various options.

"This multimedia program allows patients and their families to watch and listen to various treatment options, which we feel will help them make a more informed decision," says Diefenbach.

To be eligible to participate, the patient must have a recent diagnosis of prostate cancer and not yet have chosen any treatment.

"If your loved one has prostate cancer, pick up the phone on their behalf and make the call," says Diefenbach. "You will receive the best possible information, and your participation will help those who are diagnosed in the future."

The National Cancer Institute is funding the study with a grant to CISRC.

Approximately 217,000 men will be diagnosed with prostate cancer this year.


'/>"/>
SOURCE Cancer Information Service Research Consortium
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
3. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
6. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
7. Study Suggests Soy Protein May Reduce Prostate Cancer Risk
8. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Prostate Cancer Treatment Centre Receives Funding for Clinical Trials
11. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... ... for the National Institute for Health and Care Excellence (NICE) framework. ... the National Health Service (NHS) to search, order and purchase medical and healthcare-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... ERT, a ... today announced that Premier Research, a leading clinical development service provider, has selected ... becoming increasingly complex, due in part to an array of circumstances including the ...
(Date:2/23/2017)... ... (PRWEB) ... opportunity for the nation to come together to combine its ... – with its favorite fruit – apples! To celebrate National ... to join the “Apple Madness” bracket tournament – a five-week, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... HealthPostures, the desk ... an expert sit stand solutions representative to the Minneapolis Home and Garden Show which ... the event that is garnering national attention is the Minneapolis Convention Center. , ...
(Date:2/22/2017)... ... February 22, 2017 , ... Our high-octane society demands higher ... sharpest brain. , Power On, a mental performance enhancer from Modus Nutrition, provides ... Each capsule contains Cognizin® Citicoline, a branded form of the brain health nutrient ...
Breaking Medicine News(10 mins):